\small
\begin{tabular}{l l l l l}
\textbf{Year} & \textbf{Author} & \textbf{Protein} & \textbf{Region} & \textbf{Coverage}  \\ \hline\hline
2010 & Fowler~\etal~\cite{fowler_high-resolution_2010} & YAP65 & WW~domain & $\sim 100\%$\\
2010 & Ernst~\etal~\cite{ernst_coevolution_2010} & Synthetic PDZ domain & 10~AAs & $\sim 100\%$\\
2011 & Hietpas~\etal~\cite{hietpas_experimental_2011} & Hsp90 & 9~AAs & $\sim 100\%$\\
2012 & Fujino~\etal~\cite{fujino_robust_2012} & Fab antibody fragment & fragment & 79\% \\
2012 & Adkar~\etal~\cite{adkar_protein_2012} & Ccdb & whole protein & $< 74\%$\\
2012 & McLaughlin~\etal~\cite{mclaughlin_jr_spatial_2012} & PSD95 & PDZ domain & $\sim 100\%$\\
2012 & Schlinkmann~\etal~\cite{schlinkmann_critical_2012} & GPCR & whole protein & $\sim 90\%$\\
2012 & Whitehead~\etal~\cite{whitehead_optimization_2012} & Synthetic protein & 51AA (whole protein) & 99\%\\
2012 & Traxlmayr~\etal~\cite{traxlmayr_construction_2012} & IgG1 & CH2/CH3 domains & $< 50\%$\\
2012 & Wu~\etal~\cite{wu_systematic_2013} & Neuraminidase & SNP accessible & $<50\%$\\
2013 & Roscoe~\etal~\cite{roscoe_analyses_2013} & Ubiquitin & Whole protein & $\sim 95\%$\\
2013 & Starita~\etal~\cite{starita_activity-enhancing_2013} & Ub.E3 E4B & whole protein & $\sim 50\%$\\
2013 & Procko~\etal~\cite{procko_computational_2013} & Synthetic protein & 60 AA & $\sim 100\%$\\
2013 & Tinberg~\etal~\cite{tinberg_computational_2013} & Synthetic protein & 40AA & 90\% \\
2013 & Jiang~\etal~\cite{jiang_latent_2013} & Hsp90 & Substrate binding loop & $\sim 100\%$\\
2013 & Kim~\etal~\cite{kim_high-throughput_2013} & Mat alpha  & degron region & $< 50\%$\\
2013 & Melamed~\etal~\cite{melamed_deep_2013} & Pab1 & RRM domain & $\sim 90\%$\\
2013 & Forsyth~\etal~\cite{forsyth_deep_2013} & Antibody for EGFR & whole protein & $\sim 99\%$\\
2013 & Wagenaar~\etal~\cite{wagenaar_resistance_2014} & BRAF & 77~AAs & 99.65\%\\
2014 & Firnberg~\etal~\cite{firnberg_comprehensive_2014} & TEM1 $\beta$-lactamase & Whole protein & $\sim 95\%$\\
2014 & Olson~\etal~\cite{olson_comprehensive_2014} & G-protein (GB1) & IgG-binding domain & $\sim 95\%$ \\
2014 & Melnikov~\etal~\cite{melnikov_comprehensive_2014} & APH(3')II (kinase) & Whole protein & $\sim 100\%$\\
2014 & Bloom~\cite{bloom_experimentally_2014} & influenza nucleoprotein & whole protein & $> 75\%$\\
2014 & Thyagarajan\etal~\cite{thyagarajan_inherent_2014} & influenza hemagglutinin & whole protein & $\sim 85\%$\\
2015 & Stiffler~\etal~\cite{stiffler_evolvability_2015} & TEM1 $\beta$-lactamase & whole protein & $\sim 100\%$\\
2015 & Doud~\etal~\cite{doud_site-specific_2015} & influenza nucleoprotein & whole protein & $\sim 100\%$\\
2015 & Kitzman~\etal~\cite{kitzman_massively_2015} & Gal4 & DB domain & $\sim 99\%$\\
2015 & Starita~\etal~\cite{starita_massively_2015} & BRCA1 & RING domain & $\sim 80\%$\\
2016 & Mishra~\etal~\cite{mishra_systematic_2016} & Hsp90 & ATPase domain & $\sim 99\%$\\
2016 & Doud~\etal~\cite{doud_accurate_2016} & Hemagglutinin & whole protein & $< 97\%$\\
2016 & Mavor~\etal~\cite{mavor_determination_2016} & Ubiquitin & whole protein & $\sim 99\%$\\
2016 & Majithia~\etal~\cite{majithia_prospective_2016} & PPAR$\gamma$ & whole protein & $\sim 99\%$
\end{tabular}